Medicaid Spending on Drugs Marketed Without US Food and Drug Administration Approval in 2020.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 35040875.
- Also identified by DOI 10.1001/jamainternmed.2021.7614 and PMC identifier 8767485.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cross-sectional study examines the proportion of Medicaid prescription and spending on drugs marketed in the United States without Food and Drug Administration approval.
Medical subject headings
- Drug Approval
- Medicaid